Of particular importance for Stratum corneum (SC) lipids are the free fatty acids (FFAs). Age-related changes of the SC structure lead to diminished capacity for barrier compensation. The aims of this cross-sectional study were to identify even-numbered especially odd-numbered FFAs within the intercorneocytic lamellar lipid structures of the SC and to explore age- and diabetes-related changes in FFAs. Gas chromatography – flame ionisation detection was used to qualitatively and quantitatively assess FFAs extracted from the SC. 110 subjects aged over 60 years (elderly/healthy), 110 subjects aged 18–40 (young/healthy) and 38 subjects with diabetes mellitus aged 18–40 (young/diabetic) were investigated. Overall, odd-numbered FFAs comprised about 21, 23 and 24% of total FFAs in subgroups elderly/healthy, young/healthy and young/diabetic. The most abundant short-chain FFAs were C16: 0 and C18: 0 and long-chain FFAs were C24: 0 and C26: 0. Only levels of C15: 0 and C17: 0 decreased with age. In contrast, levels of C18: 2 and C19 were significantly decreased and levels of C15, C17, C18: 1 and C23 were significantly increased in young diabetic subjects. In general, compared with younger healthy subjects, FFA composition was only partly significantly altered in older healthy subjects but was significantly altered in younger diabetic subjects.

Keywords:
Odd-numbered free fatty acids, Stratum corneum, Gas chromatography – flame ionisation detection
1.
Weinert BT, Timiras PS: Theories of aging. J Appl Physiol 2003; 95: 1706–1716.
2.
Ouwehand C, de Ridder DT, Bensing JM: A review of successful aging models: proposing proactive coping as an important additional strategy. Clin Psychol Rev 2007; 27: 873–884.
3.
Jafferany M, Huynh TV, Silverman MA, Zaidi Z: Geriatric dermatoses: a clinical review of skin diseases in an aging population. Int J Dermatol 2012; 51: 509–522.
4.
Ghadially R, Brown BE, Sequeira-Martin SM, Feingold KR, Elias PM: The aged epidermal permeability barrier. Structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model. J Clin Invest 1995; 95: 2281–2290.
5.
Sahle FF, Gebre-Mariam T, Dobner B, Wohlrab J, Neubert RH: Skin diseases associated with the depletion of stratum corneum lipids and stratum corneum lipid substitution therapy. Skin Pharmacol Physiol 2015; 28: 42–55.
6.
Wohlrab J, Wohlrab D, Meiss F: Skin diseases in diabetes mellitus. J Dtsch Dermatol Gesell 2007; 1: 37–50.
7.
Yokota M, Tokudome Y: The effect of glycation on epidermal lipid content, its metabolism and change in barrier function. Skin Pharmacol Physiol 2016; 29: 231–242.
8.
Sakai S, Endo Y, Ozawa N, Sugawara T, Kusaka A, Sayo T, Tagami H, Inoue S: Characteristics of the epidermis and stratum corneum of hairless mice with experimentally induced diabetes mellitus. J Invest Dermatol 2003; 120: 79–85.
9.
Behm B, Kemper M, Babilas P, Abels C, Schreml S: Impact of a glycolic acid-containing ph 4 water-in-oil emulsion on skin pH. Skin Pharmacol Physiol 2015; 28: 290–295.
10.
Jackson SM, Williams ML, Feingold KR, Elias PM: Pathobiology of the stratum corneum. West J Med 1993; 158: 279–285.
11.
Elias PM: Stratum corneum architecture, metabolic activity and interactivity with subjacent cell layers. Exp Dermatol 1996; 5: 191–201.
12.
Danby SG, Brown K, Higgs-Bayliss T, Chittock J, Albenali L, Cork MJ: The effect of an emollient containing urea, ceramide NP, and lactate on skin barrier structure and function in older people with dry skin. Skin Pharmacol Physiol 2016; 29: 135–147.
13.
Elias PM: Structure and function of the stratum corneum extracellular matrix. J Invest Dermatol 2012; 132: 2131–2133.
14.
Ponec M, Kempenaar J, Boustra J: Regulation of lipid synthesis in relation to keratinocyte differentiation capacity. Biochim Biophys Acta 1987; 921: 512–521.
15.
Farwanah H, Wohlrab J, Neubert RH, Raith K: Profiling of human stratum corneum ceramides by means of normal phase LC/APCI-MS. Anal Bioanal Chem 2005; 383: 632–637.
16.
Tessema EN, Gebre-Mariam T, Neubert RHH, Wohlrab J: Potential applications of phyto-derived ceramides in improving epidermal barrier function. Skin Pharmacol Physiol 2017; 30: 115–138.
17.
Kessner D, Ruettinger A, Kiselev MA, Wartewig S, Neuebrt RH: Properties of ceramides and their impact on the stratum corneum structure. Part 2: stratum corneum lipid model systems. Skin Pharmacol Physiol 2008; 21: 58–74.
18.
Gupta R, Dwadasi BS, Rai B: Molecular dynamics simulation of skin lipids: Effect of ceramide chain lengths on bilayer properties. J Phys Chem B 2016; 120: 12536–12546.
19.
Norlén L, Plasencia I, Bagatolli L: Stratum corneum lipid organization as observed by atomic force, confocal and two-photon excitation fluorescence microscopy. Int J Cosmet Sci 2008; 30: 391–411.
20.
Schröter A, Kessner D, Kiselev MA, Hauss T, Dante S, Neubert RH: Basic nanostructure of stratum corneum lipid matrices based on ceramides (EOS) and (AP): a neutron diffraction study. Biophys J 2009; 97: 1104–1114.
21.
Katsuta Y, Iida T, Inomata S, Denda M: Unsaturated fatty acids induce calcium influx into keratinocytes and cause abnormal differentiation of epidermis. J Invest Dermatol 2005; 124: 1008–1013.
22.
Nikolakopoulou Z, Nteliopoulos G, Michael-Titus AT, Parkinson EK: Omega-3 polyunsaturated fatty acids selectively inhibit growth in neoplastic oral keratinocytes by differentially activating ERK1/2. Carcinogenesis 2013; 34: 2716–2725.
23.
Feingold KR: Thematic review series: skin lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis. J Lipid Res 2007; 48: 2531–2546.
24.
Kondo N, Ohno Y, Yamagata M, Obara T, Seki N, Kitamura T, Naganuma T, Kihara A: Identification of the phytosphingosine metabolic pathway leading to odd-numbered fatty acids. Nat Commun 2014; 5: 5338.
25.
Hinder A, Schmelzer CE, Rawlings AV, Neubert RH: Investigation of the molecular structure of the human stratum corneum ceramides (NP) and (EOS) by mass spectrometry. Skin Pharmacol Physiol 2011; 24: 127–135.
26.
Latulippe ME, Meheust A, Augustin L; Benton D, Bercik P, Birkett A, Eldridge AL, Faintuch J, Hoffmann C, Jones JM, Kendall C, Lajolo F, Perdigon G, Prieto PA, Rastall RA, Sievenpiper JL, Slavin J, de Menezes EW: ILSI Brazil international workshop on functional foods: a narrative review of the scientific evidence in the area of carbohydrates, microbiome, and health. Food Nutr Res 2013; 57: 1–18.
27.
Gurr MI, Harwood JL: Fatty acid structure and metabolism; in Lipid Biochemistry: An Intoduction (ed 4). London, Capman & Hall, 1991.
28.
Ananthapadmanabhan KP, Mukherjee S, Chandar P: Stratum corneum fatty acids: their critical role in preserving barrier integrity during cleansing. Int J Cosmet Sci 2013; 35: 337–345.
29.
Grubauer G, Feingold KR, Elias PM: Relationship of epidermal lipogenesis to cutaneous barrier function. J Lipid Res 1987; 28: 746–752.
30.
Laposata M: Fatty acids. biochemistry to clinical significance. Am J Clin Pathol 1995; 104: 172–179.
31.
Jakobsson A, Westerberg R, Jacobsson A: Fatty acid elongases in mammals: their regulation and roles in metabolism. Prog Lipid Res 2006; 45: 237–249.
32.
Feingold KR: Lamellar bodies: the key to cutaneous barrier function. J Invest Dermatol 2012; 132: 1951–1953.
33.
Jia Y, Gan Y, He C, Chen Z, Zhou C: The mechanism of skin lipids influencing skin status. J Dermatol Sci 2018; 89: 112–119.
34.
van Smeden J, Janssens M, Kaye ECJ, Caspers PJ, Lavrijsen AP, Vreeken RJ, Bouwstra JA: The importance of free fatty acid chain length for the skin barrier function in atopic eczema patients. Exp Dermatol 2014; 23: 45–52.
35.
Li S, Ganguli-Indra G, Indra AK: Lipidomic analysis of epidermal lipids: a tool to predict progression of inflammatory skin disease in humans. Expert Rev Proteomics 2016; 13: 451–456.
36.
van Smeden J, Bouwstra JA: Stratum corneum lipids: their role for the skin barrier function in healthy subjects and atopic dermatitis patients. Curr Probl Dermatol 2016; 49: 8–26.
37.
Joo KM, Hwang JH, Bae S, Nahm DH, Park HS, Ye YM, Lim KM: Relationship of ceramide-, and free fatty acid-cholesterol ratios in the stratum corneum with skin barrier function of normal, atopic dermatitis lesional and non-lesional skins. J Dermatol Sci 2015; 77: 71–74.
38.
Smesny S, Schmelzer CE, Hinder A, Kohler A, Schneider C, Rudzok M, Schmidt U, Milleit B, Milleit C, Nenadic I, Sauer H, Neubert RH, Fluhr JW: Skin ceramide alterations in first-episode schizophrenia indicate abnormal sphingolipid metabolism. Schizophr Bull 2013; 39: 933–94139.
39.
Goebel ASB, Knie U, Abels C, Wohlrab J, Neubert RH: Dermal targeting using colloidal carrier systems with linoleic acid. Eur J Pharm Biopharm 2010; 75: 162–172.
40.
Shapiro SS, Wilk MB: An analysis of variance test for normality (complete samples). Biometrika 1965; 52: 591–611.
41.
Liu RY, Singh K: A Quality index based on data depth and multivariate rank-tests. J Am Stat Assoc 1993; 88: 252–260.
42.
European Medicines Agency: Guideline on Validation of Biomanalytical Methods. Doc. Ref: EMEA/CHMP/EWP/192217/2009, 2009.
43.
Norlén L, Nicander I, Rozell BL, Olimar S, Forslind B: Inter- and intra-individual differences in human stratum corneum lipid content related to physical parameters of skin barrier function in vivo. J Invest Dermatol 1999; 112: 72–77.
44.
Norlén L, Nicander I, Lundsjo A, Cronholm T, Forslind B: A new HPLC-based method for the quantitative analysis of inner stratum corneum lipids with special reference to the free fatty acid fraction. Arch Dermatol Res 1998; 290: 508–516.
45.
Linseisen J, Wolfram G: Odd-numbered medium-chain triglycerides (trinonanoin) in total parenteral nutrition: effects on parameters of fat metabolism in rabbitis. J Parenter Enteral Nutr 1993; 17: 522–528.
46.
Nicollier M, Massengo T, Remymartin JP, Laurent R, Adessi GL: Free fatty acids and fatty acids of triacylglycerols in normal and hyperkeratotic human stratum-corneum. J Invest Dermatol 1986; 87: 68–71.
47.
Lampe MA, Burlingame AL, Whitney J, Williams ML, Brown BE, Roitman E, Elias PM: Human stratum corneum lipids: characterization and regional variations. J Lipid Res 1983; 24: 120–130.
48.
Lavrijsen APM, Higounenc IM, Weerheim A, Oestmann E, Tuinenburg EE, Bodde HE, Ponec M: Validation of an in vivo extraction method for human stratum corneum ceramides. Arch Dermatol Res 1994; 286: 495–503.
49.
Kalousek F, Darigo MD, Rosenberg LE: Isolation and characterization of propionyl-CoA carboxylase from normal human liver. Evidence for a protomeric tetramer of nonidentical subunits. J Biol Chem 1980; 255: 60–65.
50.
Elias PM, Williams ML, Holleran WM, Jiang YJ, Schmuth M: Pathogenesis of permeability barrier abnormalities in the ichthyoses: inherited disorders of lipid metabolism. J Lipid Res 2008; 49: 697–714.
51.
Rogers J, Harding C, Mayo A, Banks J, Rawlings A: Stratum corneum lipids: the effect of ageing and the seasons. Arch Dermatol Res 1996; 288: 765–770.
52.
Yosipovitch G, Tur E, Cohen O, Rusecki Y: Skin surface pH in intertriginous areas in NIDDM patients. Possible correlation to candidal intertrigo. Diabetes Care 1993; 16: 560–563.
53.
Mackiewicz-Wysocka M, Araszkiewicz A, Niedzwiedzki P, Schlaffke J, Micek I, Kuczynski S, Zozulinska-Ziolkiewicz D: Skin pH is lower in type 1 diabetes subjects and is related to glycemic control of the disease. Diabetes Technol Ther 2014; 17: 16–20.
54.
Neubert RH, Sonnenberger S, Dobner B, Gray CW Jr, Barger KN, Sevi-Maxwell K, Sommer E, Wohlrab J: Controlled penetration of a novel dimeric ceramide into and across the stratum corneum using microemulsions and various types of semisolid formulations. Skin Pharmacol Physiol 2016; 29: 130–134.
55.
Buldo P, Larsen MK, Wiking L: Multivariate data analysis for finding the relevant fatty acids contributing to the melting fractions of cream. J Sci Food Agric 2013; 93: 1620–1625.
56.
Shapiro M, Rosen GH: Topical oil applications in essential fatty acid deficiency. Nutr Clin Pract 1989; 4: 140–144.
57.
Daehnhardt D, Daehnhardt-Pfeiffer S, Schulte-Walter J, Neubourg T, Hanisch E, Schmetz C, Breuer M, Folster-Holst R: The influence of two different foam creams on skin barrier repair of foot xerosis: a prospective, double-blind, randomised, placebo-controlled intra-individual study. Skin Pharmacol Physiol 2016; 29: 266–272.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.